Macrogenics (MGNX) Asset Utilization Ratio (2013 - 2026)
Macrogenics' (MGNX) quarterly Asset Utilization Ratio came in at 0.66 in Q1 2026, down 7.9% year-on-year from 0.72 in Q1 2025, and up 16.78% on a QoQ basis from 0.57 in Q4 2025.
Macrogenics (MGNX) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Macrogenics (MGNX) has 14 years of Asset Utilization Ratio data on file, last reported at 0.66 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 7.9% year-over-year to 0.66 in Q1 2026; TTM through Mar 2026 was 0.66, a 7.9% decrease from a year earlier, with the FY2025 full-year figure at 0.58, up 7.68% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.66, up from 0.57 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for MGNX reached as high as 0.79 in Q2 2025 and fell as low as 0.16 in Q1 2024.
- Historically, Asset Utilization Ratio has averaged 0.47 across 5 years, with a median of 0.53 in 2023.
- Across the five-year window, Asset Utilization Ratio tumbled 71.18% in 2023 and soared 353.05% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.64 in 2022, then tumbled by 71.18% to 0.18 in 2023, then jumped by 252.35% to 0.65 in 2024, then declined by 12.62% to 0.57 in 2025, then grew by 16.78% to 0.66 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.66 in Q1 2026, 0.57 in Q4 2025, and 0.57 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 0.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.66 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.57 |
| Jun 30, 2025 | 0.79 |
| Mar 31, 2025 | 0.72 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.61 |
| Jun 30, 2024 | 0.18 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.18 |
| Sep 30, 2023 | 0.38 |
| Jun 30, 2023 | 0.47 |
| Mar 31, 2023 | 0.53 |
| Dec 31, 2022 | 0.64 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.27 |
| Mar 31, 2022 | 0.24 |
| Dec 31, 2021 | 0.21 |
| Sep 30, 2021 | 0.20 |
| Jun 30, 2021 | 0.20 |